Analyst Ratings For Cogentix Medical (NASDAQ:CGNT)
Today, Cogentix Medical (NASDAQ:CGNT) stock was downgraded by Aegis from Buy to Hold.
Some recent analyst ratings include
- 3/13/2018-Aegis was Downgraded by analysts at Aegis from a “Buy ” rating to a ” Hold” rating.
- 11/8/2017-Roth Capital initiated coverage with a Buy rating.
- 10/6/2017-JMP Securities initiated coverage with a Mkt Outperform rating.
Recent Insider Trading Activity For Cogentix Medical (NASDAQ:CGNT)
Cogentix Medical (NASDAQ:CGNT) has insider ownership of 62.70% and institutional ownership of 14.52%.
- On 11/18/2016 Kenneth A Samet, Director, bought 25,000 with an average share price of $2.47 per share and the total transaction amounting to $61,750.00.
- On 6/10/2016 Lewis C Pell, Director, bought 13,291 with an average share price of $0.95 per share and the total transaction amounting to $12,626.45.
- On 6/1/2016 Lewis C Pell, Director, bought 894 with an average share price of $0.75 per share and the total transaction amounting to $670.50.
- On 5/31/2016 Lewis C Pell, Director, bought 500,000 with an average share price of $0.79 per share and the total transaction amounting to $395,000.00.
- On 5/21/2015 Kevin H Roche, Director, bought 10,000 with an average share price of $1.68 per share and the total transaction amounting to $16,800.00.
- On 5/19/2015 Kevin H Roche, Director, bought 10,000 with an average share price of $1.60 per share and the total transaction amounting to $16,000.00.
- On 2/20/2015 Lewis C Pell, Director, bought 20,000 with an average share price of $0.51 per share and the total transaction amounting to $10,200.00.
Recent Trading Activity for Cogentix Medical (NASDAQ:CGNT)
Shares of Cogentix Medical closed the previous trading session at with 3.8299999237060547 shares trading hands.